Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma

Leuk Lymphoma. 2019 Oct;60(10):2558-2562. doi: 10.1080/10428194.2019.1585836. Epub 2019 Mar 8.

Binod Dhakal¹, Adam Pagenkopf^{2

3}, Muhammad Umair Mushtaq^{2

3}, Ashley M Cunningham⁴, Evan Flietner^{2

3}, Zachary Morrow^{2

3}, Athanasios Papadas^{2

3}, Chelsea Hope^{2

3}, Catherine Leith⁵, Peiman Hematti^{2

3}, Parameswaran Hari¹, Natalie S Callander^{2

3}, Fotis Asimakopoulos^{2

3}

¹ Department of Medicine, Division of Hematology/Oncology, Medical College of Wisconsin , Milwaukee , WI , USA.
² Department of Medicine, Division of Hematology-Oncology, University of Wisconsin-Madison , Madison , WI , USA.
³ University of Wisconsin Carbone Cancer Center , Madison , WI , USA.
⁴ Division of Pathology and Laboratory Medicine, Medical College of Wisconsin , Milwaukee , WI , USA.
⁵ Division of Pathology and Laboratory Medicine, University of Wisconsin-Madison , Madison , WI , USA.

No abstract available

Publication types